Jaffetilchin Investment Partners’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-472
| Closed | -$8.51K | – | 1207 |
|
|
2024
Q3 | $8.51K | Buy |
+472
| New | +$8.51K | ﹤0.01% | 926 |
|
|
2023
Q4 | – | Sell |
-23,578
| Closed | -$240K | – | 375 |
|
|
2023
Q3 | $240K | Buy |
+23,578
| New | +$240K | 0.03% | 298 |
|
|
2021
Q4 | – | Sell |
-14,855
| Closed | -$145K | – | 384 |
|
|
2021
Q3 | $145K | Sell |
14,855
-23,175
| -61% | -$226K | 0.02% | 350 |
|
|
2021
Q2 | $371K | Buy |
38,030
+21,665
| +132% | +$211K | 0.03% | 301 |
|
|
2021
Q1 | $189K | Sell |
16,365
-4,600
| -22% | -$53.1K | 0.02% | 344 |
|
|
2020
Q4 | $202K | Buy |
+20,965
| New | +$202K | 0.03% | 262 |
|
|
2018
Q3 | – | Sell |
-47,527
| Closed | -$1.16M | – | 337 |
|
|
2018
Q2 | $1.16M | Buy |
+47,527
| New | +$1.16M | 0.26% | 71 |
|
|
2014
Q3 | – | Sell |
-9,532
| Closed | -$500K | – | 241 |
|
|
2014
Q2 | $500K | Buy |
+9,532
| New | +$500K | 0.18% | 93 |
|